Location: Home
  • search
  • go
  • Relate News
  • 3/30/2022IQVIA: Chinese Retail Pharmacy Sales Up 0.6% in Q4/2021
  • 3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability
  • 3/29/2022NHC and NMPA Solicits Comments on Two Documents on Temporary Import Wo...
  • 3/29/2022Shanghai Lockdown May Choke Pharma Supplies (ET)
  • 3/28/2022Fosun Pharma Hopes Covid Vaccine Can Cure Its Ailing Margins
  • 3/28/2022Innovent and Lilly Expand Strategic Partnership in Oncology
  • 3/28/2022Upcoming Event: 5th European Meeting on Materials Science and Nanotech...
  • 3/28/2022China Approves Takeda's Lung Cancer Drug Brigatinib
  • 3/28/2022BRICS Launches Vaccine R&D Center
  • 3/25/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (57...
  • 3/25/2022Drug R&D and Product Registration News Digest March 2022 (4)
  • 3/24/2022Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chine...
  • 3/24/2022Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...
  • 3/24/2022Eli Lilly/Innovent Announce Lung Cancer Drug Rejection by FDA Citing...
  • 3/24/2022What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)
  • 3/24/2022New Use Claims in China - Santen Pharma v. Jiangsu Hengrui Medicine
  • 3/24/2022Preplanned Studies: Disease Burden of Pancreatic Cancer — China, 1990...
  • 3/24/2022Bracing for Volume-Based Procurement in China (Simon Kucher)
  • 3/24/2022Hong Kong Remained Asia's Largest Biotech Fundraising Hub in 2021 (Pha...
  • 3/23/2022PharmCube: Review of Global and Chinese Cross-border Biopharma Transac...
  • 3/23/2022MOST Releases the Implementation Rules for the Regulations on the Mana...
  • 3/22/2022NMPA Solicits Comments on the Draft of GSP's Appendix for Quality Cont...
  • 3/22/2022Transcenta Announces Global Clinical Collaboration with BMS to Evaluat...
  • 3/22/2022PharmaDJ's China Deals Tracker: February 2022
  • 3/22/2022The Evolving Treatment Paradigm of Lung Cancer in China (ScienceDirect...
  • 3/22/2022China Biotech Firms Stunned by US Drug Trial U-Turn (Asia Financial)
  • 3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
  • 3/21/2022Bavarian Nordic and Nuance Pharma Enter License for RSV Vaccine for ...
  • 3/21/2022China's Triastek and Siemens Strive to Accelerate Digital Transformati...
  • 3/20/2022FT: China Plans Audit Concession in Face of US Delisting Threat
  • Page:146/775 Total number of articles:23233: [First][<<] [144] [145] [146] [147] [148] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group